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ABSTRACT
Endonuclease IV encoded by denB of bacteriophage
T4 is implicated in restriction of deoxycytidine
(dC)-containing DNA in the host Escherichia coli.
The enzyme was synthesized with the use of a wheat
germ cell-free protein synthesis system, given a
lethal effect of its expression in E.coli cells, and was
purified to homogeneity. The purified enzyme
showed high activity with single-stranded (ss) DNA
and denatured dC-substituted T4 genomic double-
stranded (ds) DNA but exhibited no activity with
dsDNA, ssRNA or denatured T4 genomic dsDNA
containing glucosylated deoxyhydroxymethylcytid-
ine. Characterization of Endo IV activity revealed
that the enzyme catalyzed specific endonucleolytic
cleavage of the 50 phosphodiester bond of dC in
ssDNA with an efficiency markedly dependent on
the surrounding nucleotide sequence. The enzyme
preferentially targeted 50-dTdCdA-30 but tolerated
various combinations of individual nucleotides
flanking this trinucleotide sequence. These results
suggest that Endo IV preferentially recognizes
short nucleotide sequences containing 50-dTdCdA-30,
which likely accounts for the limited digestion of
ssDNA by the enzyme and may be responsible in part
for the indispensability of a deficiency in denB for
stable synthesis of dC-substituted T4 genomic DNA.
INTRODUCTION
Infection of Escherichia coli by T4 phage is followed by
degradation of genomic DNA of the host cell to provide
nucleotides for the synthesis of T4 genomic DNA, in which
all deoxycytidine (dC) residues are replaced by glucosylated
deoxyhydroxymethylcytidine (gluc-dHMC) (1,2). At least two
T4 endonucleases [Endo II and Endo IV, encoded by denA
(3) and denB (4), respectively] are thought to participate in
the degradation of host DNA, with T4 genomic DNA being
normally protected from cleavage by the presence of gluc-
dHMC (1,2,5,6). The Endo II protein is essential for this
degradation of host DNA whereas the Endo IV protein is
not (3,7,8).
The Endo II and Endo IV proteins are composed of 136
and 185 amino acid residues, respectively, and their biochem-
ical properties have been examined with partially puriﬁed
enzyme preparations from E.coli cells infected with T4
(9–11). Both enzymes require Mg
2+ for activity and do not
cleave T4 genomic DNA containing gluc-dHMC. Although
Endo II acts on double-stranded (ds) DNA and generates 50
termini containing predominantly dG or dC, Endo IV acts
on single-stranded (ss) DNA and generates 50 termini contain-
ing exclusively dC. Speciﬁc roles for Endo II and Endo IV
in the degradation of host genomic DNA have been proposed
on the basis of their biochemical properties (9,10). Endo II is
thought to introduce a nick in host genomic dsDNA, and the
46/47 exonuclease, encoded by gene 46 and gene 47,
subsequently removes mononucleotides from the internal
30-hydroxyl terminus and thereby exposes a region of
ssDNA on the opposite strand. This exposed ssDNA region
is cleaved by Endo IV and yields dsDNA fragments.
T4 phage with mutations in gene 42 (which encodes dCMP
hydroxymethylase), gene 56 (which encodes dCTPase) and
denB synthesize a completely dC-substituted T4 (T4dC)
genomic DNA (12). An additional mutation in alc (unf),
whose product shuts off transcription of T4dC DNA (13),
results in the generation of a plaque-forming T4 phage con-
taining dC-substituted DNA (T4dC phage). T4dC phage is
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in vitro (12,14,15). A deﬁciency in denB, but not in denA,
is required for synthesis of stable T4dC genomic DNA in a
gene 56
  (6,16,17) or gene 42
 , gene 46
 , gene 56
  (6) back-
ground, even though the denA product (Endo II) plays a
major role in the degradation of dC-containing host DNA
(5). These observations suggest the possibility that the denB
product (Endo IV) plays a crucial role in inhibition of the rep-
lication of dC-containing DNA rather than in its degradation.
The mechanism of substrate recognition by Endo II
has been studied extensively in vivo (18–20) and in vitro
(9,21,22), given the major role of the enzyme in degradation
of dC-containing T4 (5) and host (3,7,8) DNA. In contrast,
the substrate recognition mechanism of Endo IV has been
less well characterized (10,11,23,24). Moreover, the small
number of Endo IV-related proteins in the genome sequence
databases has limited the amount of insight provided by such
proteins into the mechanism of Endo IV action.
We have now shown that a low level of expression of denB
is highly toxic to E.coli cells. We therefore synthesized Endo
IV with a wheat germ cell-free protein synthesis system (25)
and puriﬁed it to homogeneity without the need for cloning of
denB into an expression vector (26,27). Analysis of the
substrate speciﬁcity and sequence preference of the highly
puriﬁed enzyme indicated that it speciﬁcally cleaves the 50
phosphodiester bond of dC in ssDNA with an efﬁciency
that depends markedly on the surrounding nucleotides. A
preference of the enzyme for a 50-dTdCdA-30 trinucleotide
sequence was revealed.
MATERIALS AND METHODS
Materials
Restriction and other enzymes for recombinant DNA tech-
nology were obtained from Takara Shuzo. T4 and T4dC
genomic DNA were prepared as described previously (28).
Cells and plasmids
The plasmid pEUGFP was constructed as described previ-
ously (27) and pGEX-6P-1 was obtained from Amersham
Biosciences. E.coli strain KH5402-1 [ilv, thyA, thr (amber),
trpE9829 (amber), metE, deo, supF6 (Ts)] (29) was provided
by the National Institute of Genetics (Japan). T4dC phage
[gene 42 (amC87), gene 56 (amE51), denB( s19), alc
(unf39)] was constructed as described previously (15).
The plasmid pBRdenB
am was constructed for the present
study. The nucleotide sequence of denB has been deposited
in EMBL/GenBank/DDBJ under the accession number
NC_000866.4 (167103–167660) and in Entrez Gene with
the GeneID 1258726. The denB
am gene, in which the TAC
codon for Tyr
38 is replaced with a TAG nonsense codon,
was constructed by the PCR with a 50 primer containing a
BamHI site (50-CTACAGGATCCGAAGGAGATATACAT-
ATGCAGAAAACGAATCCTGG-30, with the BamHI site
underlined, the initiation codon in boldface and the Shine–
Dalgarno sequence in italics) and a 30 primer containing a
SalI site (50-AAAACCATGGGACGTCGACTTAAATGGA-
AAGATACCATCCGTTG-30, with the complementary
sequence of the termination codon in boldface and the SalI
site underlined) as well as 50 and 30 mutagenic primers
(50-TGCAAGATAGTCTTTAAAACAAAACC-30 and 50-
TTTTAAAGACTATCTTGCAGTATCAGC-30, with the
sequence and complementary sequence, respectively, of the
TAG nonsense codon that replaces the TAC codon for Tyr
38
shown in boldface). The upstream and downstream regions of
denB in T4 genomic DNA were ampliﬁed by PCR with the 50
primer and the 30 mutagenic primer and with the 50 mutagenic
primer and the 30 primer, respectively. The ampliﬁed DNA
fragments were puriﬁed by gel electrophoresis, mixed (each
at a ﬁnal concentration of 5 nM) and subjected to a second
round of PCR with the 50 and 30 primers. The DNA fragment
generated by the second-round PCR was introduced into
the BamHI–SalI sites of pBR322 (Takara Shuzo) to yield
pBRdenB
am and was cloned in non-amber-suppressing host
cells. The nucleotide sequence of the denB
am gene was det-
ermined by the dideoxy chain termination method. All PCR
primers were synthesized by Sigma-Aldrich. PCR was per-
formed for 25 cycles of incubation at 96 C for 30 s, at
55 C for 30 s and at 72 C for 60 s with Ex Taq DNA poly-
merase (Takara Shuzo) in a Takara PCR Thermal Cycler MP.
The effect of denB expression on E.coli cell growth
was examined by comparison of the plating efﬁciencies of
E.coli KH5402-1 cells harboring pBRdenB
am and grown at
30 or 42 C. The E.coli KH5402-1 cells were transformed
with pBRdenB
am and the transformants were spread on a
Luria–Bertani (LB) agar plate containing thymine and ampi-
cillin at 2 and 100 mg/ml, respectively (LB-Thy-Amp), and
were incubated at 42 C. A single transformant was selected
and grown overnight at 42 C in LB-Thy-Amp liquid broth.
The resulting cells were spread on two LB-Thy-Amp
agar plates, one of which was incubated at 42 C and the
other at 30 C. Given that E.coli KH5402-1 cells harbor a
temperature-sensitive (Ts) allele of the supF suppressor
gene (29), the cells transformed with pBRdenB
am would be
expected to produce the active Endo IV protein when
grown at 30 C but not at 42 C.
Construction of a DNA fragment encoding a GST-endo
IV fusion protein
To construct a DNA fragment encoding a glutathione
S-transferase (GST) fusion protein of Endo IV, we ampliﬁed
DNA fragments corresponding to the 50-untranslated region
(50-UTR), GST, Endo IV and 30-UTR by PCR and assembled
them with a second-round PCR. For construction of the DNA
fragment corresponding to the 50-UTR, the region of
pEUGFP containing the promoter sequence for SP6 RNA
polymerase and the omega sequence was ampliﬁed by PCR
with a 50 primer (50-ATACATAAGCTTATGTATCATACA-
CATACG-30, primer 1) and a 30 primer (50-CATATGACTA-
GTGGCTGTAG-30, with the complementary sequence of the
initiation codon for the GST-Endo IV fusion protein shown in
boldface).
For construction of the open reading frame for the GST
portion of the GST-Endo IV fusion protein, the GST gene
in pGEX-6P-1 was ampliﬁed by PCR with a 50 primer (50-
CTACAGCCACTAGTCATATGGAATCCCCTATACTAGG-
30, with the sequence of the initiation codon for the fusion
protein shown in boldface and the ﬁrst 20 bases of the GST
gene in italics) and a 30 primer (50-TCCCAGGGGCCCCTG-
GAACAGAACTTCCAG ATCCGATTTTGGAGG-30,w i t ht h e
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nition site underlined and the complementary sequence of the
last 15 bases of the GST gene italicized).
For construction of the open reading frame for the Endo IV
portion of the fusion protein, the denB gene was ampliﬁed
from T4 genomic DNA by PCR with a 50 primer (50-TTCC-
AGGGGCCCCTGGGATCCATGCAGAAAACGAATCCTGG-
30, with a partial sequence for the PreScission protease recog-
nition site underlined and the sequence of the ﬁrst 20 bases of
denB in italics) and a 30 primer (50-AAAACCATGGGACGT-
CGACTTAAATGGAAAGATACCATCCGTTG-30, with the
complementary sequence of the termination codon for the
fusion protein shown in boldface and the last 22 bases of
denB italicized).
For construction of the DNA fragment corresponding to
the 30-UTR, the region of pEUGFP containing the 30-UTR
of tobacco mosaic virus was ampliﬁed by PCR with a 50 pri-
mer (50-TAAGTCGACGTCCCATGGTTTTG-30, with the
termination codon of the fusion protein shown in boldface)
and a 30 primer (50-GGAGAAAGGCGGACAGGTAT-30,
designated primer 2, which hybridizes 1175 bases down-
stream of the termination codon of the GFP gene in
pEUGFP).
The four DNA fragments corresponding to the 50-UTR,
coding region and 30-UTR of the GST-Endo IV fusion protein
were puriﬁed by gel electrophoresis, mixed (each at a ﬁnal
concentration of 5 nM) and subjected to a second round of
PCR without primers. The resulting DNA fragment was
further ampliﬁed by a third round of PCR with primer 1
and a 30 primer (50-CCGGTAAGCGGCAGGGTCGG-30, des-
ignated primer 3, which hybridizes 1 base upstream of the
sequence corresponding to primer 2). Given that the yield
of the third-round PCR was low, the amplicon was further
ampliﬁed by a fourth round of PCR with a 50 primer
(50-ACATACGATTTAGGTGACACTA-30, with a partial
sequence of the promoter element for SP6 RNA polymerase
underlined) and primer 3. The DNA fragment for the GST-
Endo IV fusion protein generated by the fourth-round PCR
was transcribed as described previously (26), and the result-
ing mRNA was translated in a wheat germ cell-free protein
synthesis system.
Cell-free protein synthesis
Conditions for the wheat germ cell-free protein synthesis
system with a dialysis cup (molecular size cutoff of 12000
Da; Daiichi Pure Chemicals) were as described previously
(27), with slight modiﬁcations. The internal reaction mixture
(100 ml) was as described previously (27) with the exception
that 20% wheat germ extract (Zoegene) was included and
GTP was omitted. The external solution (1 ml) contained
the same components as the internal reaction mixture with
the exception that creatine kinase, RNasin (RNase inhibitor,
Promega) and wheat germ extract were omitted. The dialysis
unit containing the reaction mixture was incubated at 26 C
for 96h, with the original amount of substrate mRNA being
supplemented and the external solution changed every 24 h.
Protein purification
For puriﬁcation of the GST-Endo IV fusion protein synthes-
ized in the wheat germ cell-free protein synthesis system, the
translation mixture was centrifuged at 20000 g for 15 min
at 4 C and the resulting supernatant was diluted 6-fold
with phosphate-buffered saline and applied to a glutathione–
Sepharose 4B MicroSpin column (Amersham Biosciences).
The GST-Endo IV fusion protein was then cleaved in the col-
umn by incubation with PreScission protease (10 U/ml;
Amersham Biosciences) for 4 h at 4 C. The ﬂow-through
fraction obtained after protease treatment contained a protein
of the predicted size for Endo IV (21.1 kDa) as revealed by
SDS–PAGE on a 12% gel and staining with Coomassie
brilliant blue. The protein concentration of this fraction was
estimated by densitometric analysis with NIH Image soft-
ware, with the use of trypsin inhibitor (20.1 kDa) as a
standard.
Endo IV assay
Assay of Endo IV activity was performed by incubation of
enzyme and substrate for 30 min at 37 C in a reaction mix-
ture (20 ml) containing 10 mM Tris–HCl (pH 8.0), 10 mM
MgCl2, 1 mM DTT and BSA (0.1 mg/ml). Puriﬁed Endo
IV was diluted in a solution containing 10 mM Tris–HCl
(pH 8.0), 1 mM DTT and BSA (0.1 mg/ml) and was included
in the reaction mixture in a volume of 1 ml. phiX174 replic-
ative form I (RFI) circular dsDNA (New England BioLabs),
phiX174 RFI linear dsDNA prepared by PstI digestion,
phiX174 virion circular ssDNA (New England BioLabs), lin-
ear ssRNA used for synthesis of the GST-Endo IV fusion pro-
tein, and heat-denatured T4 or T4dC genomic dsDNA were
used as substrates at a ﬁnal concentration of 5 mg/ml. The
ﬁnal concentration of the enzyme was varied from 0.05 to
1 mg/ml. The reaction was stopped by the addition of 20 ml
of 25 mM EDTA (pH 8.0), and the reaction products were
separated by electrophoresis on a 1.0% agarose gel and
stained with SYBR Gold (Invitrogen).
Cleavage of a phiX174-based oligonucleotide
by Endo IV
A 45 base oligonucleotide (50-TTGGATGAGGAGAAGTG-
GCTTAATATGCTTGGCACGTTCGTCAAG-30) based on
the phiX174 virion ssDNA sequence and labeled at the 50
end with Cy5 was used as a substrate. Hydrolysis of the sub-
strate (10 mM) was performed as described above for the
Endo IV assay at an enzyme concentration of 0.33–6.6 mg/ml.
The reaction products were fractionated by electrophoresis
on a 10% polyacrylamide gel containing 7 M urea and were
visualized with a Variable Image Analyzer Typhoon 8600
(Amersham Biosciences).
Kinetic analysis of Endo IV activity
Hydrolysis of unlabeled oligonucleotide substrates (10 mM)
was performed as described above for the Endo IV assay.
The reaction was stopped by the addition of 30 mlo f
25 mM EDTA (pH 8.0) and 50 ml of 10% trichloroacetic
acid. The resulting mixture (100 ml) was maintained on ice
for 15 min and then centrifuged at 5000 g for 15 min at
4 C. The amount of acid-soluble nucleotides in the supernat-
ant fraction was quantiﬁed by measurement of absorbance at
260 nm, with molar absorption coefﬁcients of 15200, 7050,
12010 and 8400 M
 1cm
 1 for dA, dC, dG and dT, res-
pectively. One unit was deﬁned as the amount of enzyme
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speciﬁc activity was deﬁned as the enzymatic activity per
milligram of enzyme. The amount of enzyme was varied
such that the amount of product increased in proportion to
that of the enzyme. For determination of kinetic parameters,
unlabeled oligonucleotides with a single cleavage site were
used as the substrate. The concentration of the substrate
was also varied from 2.5 to 25 mM such that it spanned the
Km. All oligonucleotide substrates were synthesized by
Sigma-Aldrich.
RESULTS
Detrimental effect of denB expression on E.coli growth
Attempts to clone the wild-type denB gene in several differ-
ent expression vectors, including pET21a (under strict control
of the T7 promoter), were unsuccessful, presumably because
of a highly toxic effect of the denB product (Endo IV) on
the host E.coli cells. We therefore examined the effect of
Endo IV on E.coli by transformation of KH5402-1 (supF6
Ts)
cells, which harbor a temperature-sensitive allele of the supF
suppressor gene (29), with a plasmid containing an amber
mutant allele of denB, in which the TAC codon for Tyr
38 is
mutated to a TAG nonsense codon. Cells cultured at 30 C
would thus be expected to produce the intact Endo IV protein
whereas those cultured at 42 C would not.
Culture at 30 C of the cells transformed with pBRdenB
am
reduced colony-forming ability by a factor of  10
4 compared
with that apparent at 42 C (Table 1). However, cells of most
(99%) of the original colonies that formed at 30 C did not
give rise to colonies in the presence of the selection drug
(ampicillin) at 42 C, indicating that most of the colonies
that formed at 30 C consisted of cells that did not harbor
pBRdenB
am. These results thus suggested that no E.coli cells
that expressed the active Endo IV protein were viable and
that Endo IV targets an activity, such as DNA replication, that
is indispensable for host cell growth.
Cell-free synthesis and purification of Endo IV
Given that Endo IV was found to be highly toxic to E.coli
cells, we synthesized the enzyme as a GST fusion protein
by in vitro translation with a wheat germ cell-free protein
synthesis system. The yield of the fusion protein was
 400 mg per milliliter of the translation mixture, as estimated
by SDS–PAGE and densitometric analysis (Figure 1). The
synthesized fusion protein was recovered in soluble form,
puriﬁed to homogeneity by glutathione afﬁnity chromato-
graphy, and cleaved to yield the Endo IV moiety. The amount
of Endo IV puriﬁed from 1 ml of the translation mixture was
 100 mg.
Substrate specificity of Endo IV
Optimal pH, optimal concentrations of several divalent
cations, and inhibition by several salts for Endo IV activity,
which were reported previously in detail (10), were as fol-
lows. The enzyme exhibited the activity in the presence of
several different divalent cations, Ca
2+,C o
2+,M g
2+ or
Mn
2+, and the optimal MgCl2 concentration was 10 mM.
The enzyme exhibited a pH optimum between 8.4 and 9.2.
The enzymatic activity was sensitive to several salts. The
enzymatic activity in the presence of 50 mM NaCl or KCl
was 15 or 20% of that in the absence of salts, respectively.
Therefore, the Endo IV assay in the present study was per-
formed under the conditions similar to the reported optimal
conditions for Endo IV activity.
The substrate speciﬁcity of Endo IV was investigated pre-
viously with an enzyme preparation partially puriﬁed from T4
phage-infected E.coli B cells (10,11). Given the possibility
that this preparation might have been contaminated with
other nucleases, we examined the substrate speciﬁcity of
the enzyme translated in vitro and puriﬁed to homogeneity.
With phiX174 circular dsDNA (Figure 2A), phiX174 linear
dsDNA (Figure 2B) or the linear ssRNA used for synthesis
of the GST-Endo IV fusion protein (Figure 2D) as the
substrate, no degradation was detected even in the presence
of the enzyme at a concentration of 1 mg/ml. With phiX174
Table 1. Effect of denB expression on E.coli growth
Plasmid No. of colonies
formed at 30 C
No. of colonies
formed at 42 C
30 /42 C ratio
pBRdenB
am 795
a 281 · 10
4 2.8 · 10
 4
pBR322 309 · 10
4 445 · 10
4 0.69
The effect of denB expression on E.coli cell growth was examined as
described in Materials and Methods. Data are means from three independent
experiments.
aA total of 156 colonies formed at 30 C by cells transformed with pBRdenB
am
was tested for colony-forming ability on LB-Thy or LB-Thy-Amp agar plates
at 42 C. Cells of all the original 156 colonies formed colonies on the LB-Thy
agar plate at 42 C, but cells of 154 of these 156 original colonies ( 99%) did
not form colonies on the LB-Thy-Amp agar plate at 42 C, indicating that most
of the original colonies formed at 30 C consisted of cells lacking pBRdenB
am.
Figure 1. SDS–PAGE analysis of the cell-free synthesis and purification of
Endo IV. Endo IV was synthesized as a GST fusion protein by in vitro
translation and purified as described in Materials and Methods. Samples at
various stages of the purification procedure were subjected to SDS–PAGE on
a 12% gel and stained with Coomassie brilliant blue. Lane 1, molecular size
standards; lane 2, a translation mixture incubated in the absence of mRNA;
lane 3, a translation mixture incubated in the presence of mRNA; lanes 4 and
5, the soluble and insoluble fractions, respectively, of the translation mixture
incubated in the presence of mRNA; lanes 6 and 7, the flow-through fractions
of a glutathione–Sepharose 4B MicroSpin column for the sample in lane 4
before and after, respectively, treatment of column-bound proteins with
PreScission protease. The bands corresponding to the GST-Endo IV fusion
protein in lane 3 and the purified Endo IV protein in lane 7 are indicated by
asterisks.
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amount of cleavage products was generated (Figure 2C). In
addition, the enzyme mediated a marked extent of cleavage
of heat-denatured T4dC genomic dsDNA (Figure 2F), but it
had no effect on heat-denatured T4 genomic dsDNA contain-
ing gluc-dHMC (Figure 2E). These results indicated that
Endo IV catalyzes endonucleolytic cleavage of dC-containing
ssDNA.
We next analyzed the nucleotide speciﬁcity of Endo IV
by quantifying the amount of acid-soluble nucleotides
liberated by the enzyme from 45 base oligo(dA) [(dA)45],
(dT)45, (dG)45 or (dC)45 substrates. All of the oligonucleotide
substrates used in the present study were precipitable by tri-
chloroacetic acid under the assay conditions before treatment
with Endo IV. Of the four 45 base homo-oligomers tested,
only (dC)45 was hydrolyzed by Endo IV (Table 2).
Together, our results indicated that Endo IV endonuc-
leolytically and speciﬁcally cleaves ssDNA at dC, consistent
with the previous results obtained with the partially puriﬁed
enzyme (10,11), and that the enzyme does not possess ribo-
nuclease activity. In addition, the enzyme processed both
phiX174 circular ssDNA (Figure 2C) and heat-denatured
T4dC genomic dsDNA (Figure 2F) substrates to oligonuc-
leotides comprising several hundred bases, suggesting that
digestion at dC was limited in each substrate and that the
sequence surrounding dC or the size of dC-containing oligo-
nucleotides might affect the cleavage efﬁciency.
Cleavage of a phiX174-derived oligonucleotide
To conﬁrm the dC-speciﬁc cleavage of ssDNA by Endo IV,
we examined the cleavage of a 45 base oligonucleotide
based on the phiX174 ssDNA sequence and labeled at
the 50 end with Cy5. The cleavage products were separated
by electrophoresis on a polyacrylamide gel containing 7 M
urea. The substrate contains six dC residues at positions 19,
28, 33, 35, 39 and 42. Cleavage at 50 phosphodiester bonds
of dA, dT or dG was not detected (Figure 3). The enzyme
cleaved the substrate at three sites, dG18–dC19, dG27–
dC28 and dG32–dC33, with an apparent preference for cleav-
age at the latter site. No cleavage at dA34–dC35, dT38–dC39
or dT41–dC42 was observed. At the maximal Endo IV
concentration of 6.6 mg/ml, a proportion of the substrate
molecules remained intact at the end of the 30 min incuba-
tion. If the enzyme efﬁciently cleaved the substrate at
dA34–dC35, dT38–dC39 or dT41–dC42 under these con-
ditions, the cleavage products would have been detected on
the gel. It is therefore unlikely that the enzyme efﬁciently
cleaves the substrate at these sites under these conditions.
These results indicated that Endo IV speciﬁcally cleaves
the 50 phosphodiester bond of dC in ssDNA but that it does
so with markedly different efﬁciencies depending on the
sequence surrounding dC or the size of the dC-containing
oligonucleotide.
Design of an oligonucleotide with a single cleavage site
Given that oligo(dC) substrates are unsuitable for rigorous
kinetic analysis of Endo IV activity because of the multipli-
city of cleavage sites, we designed an oligonucleotide
substrate with a single cleavage site. The activity of Endo
IV with the 25 base oligonucleotide 50-(dA)12dC(dA)12-30
as substrate was 1.8% of that apparent with (dC)45, whereas
the enzymatic activity with (dC)25 was identical to that for
(dC)45 (Table 2). The decrease in the length of the oligo(dC)
substrate from 45 to 25 bases thus did not affect cleavage efﬁ-
ciency. We conﬁrmed that the 50 and 30 products of cleavage
of 50-(dA)12dC(dA)12-30, presumably at the 50 phosphodiester
bond of the internal dC, were acid-soluble under the assay
conditions (data not shown). The reduced activity of Endo
IV with this substrate compared with that apparent for
(dC)25 was likely due to the reduced number of potential
cleavage sites. This notion was supported by the observation
that the amount of enzyme required for cleavage of this sub-
strate did not differ markedly from that required for cleavage
at either dG18–dC19 or dG27–dC28 of the phiX174 oligo-
nucleotide substrate (data not shown). We therefore used
Figure 2. Substrate specificity of Endo IV. The activity of Endo IV (1, 0.5,
0.2, 0.1 or 0.05 mg/ml) was assayed with phiX174 RFI circular dsDNA
(A), phiX174 RFI linear dsDNA (B), phiX174 virion circular ssDNA
(C), linear ssRNA used for the in vitro synthesis of the GST-Endo IV fusion
protein (D), heat-denatured T4 genomic dsDNA containing gluc-dHMC
(E), or heat-denatured dC-substituted T4 (T4dC) genomic dsDNA (F) as the
substrate (5 mg/ml). The reaction products were separated by electrophoresis
on a 1.0% agarose gel and stained with SYBR Gold. Lanes M and (–) contain
a 1 kb DNA ladder and a reaction mixture incubated in the absence of the
enzyme, respectively.
Table 2. Enzymatic activity of Endo IV with various oligonucleotides
Oligonucleotide Relative activity (%)
(dA)45 <0.3
a
(dT)45 <0.3
a
(dG)45 <0.3
a
(dC)45 100
(dC)25 100
50-(dA)12dC(dA)12-30 1.8
The activity of Endo IV was determined by measurement of the amount of
acid-soluble nucleotides released from the substrate (10 mM). The specific
activity of the enzyme for the (dC)45 substrate was  8.0 U/mg. Relative activ-
ity was calculated by dividing the enzymatic activity for each substrate by that
for the (dC)45 substrate. Data are means from two independent experiments.
aActivity did not exceed the background level.
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to examine the sequence preference and kinetic parameters of
Endo IV.
Sequence preference of Endo IV
To examine whether combinations of individual nucleotides
ﬂanking each side of the dC residue in the substrate affect
the cleavage efﬁciency of Endo IV, we determined enzymatic
activity with a series of 19 base 50-(dA)8dDdCdD(dA)8-30
oligonucleotides, where dD represents dA, dT or dG. The
activity of Endo IV with 50-(dA)8dAdCdA(dA)8-30 as sub-
strate was 1.8% of that apparent with (dC)25 (Figure 4A)
and identical to that apparent with 50-(dA)12dC(dA)12-30
(Table 2). The decrease in the length of the latter substrate
from 25 to 19 bases thus did not affect cleavage efﬁciency.
Among all examined sequences, only 50-dTdCdA-30 was sub-
stantially (3.6 times) more susceptible to enzymatic cleavage
than was 50-dAdCdA-30 (Figure 4A), indicating that Endo IV
has a preference for the former trinucleotide sequence.
To examine further whether combinations of individual
nucleotides ﬂanking the 50-dTdCdA-30 sequence affect
cleavage efﬁciency, we determined enzymatic activity with
a series of 21 base 50-(dA)8dDdTdCdAdD(dA)8-30 oligonuc-
leotides as substrates. Although both 50-dTdTdCdAdT-30 and
50-dGdTdCdAdT-30 sequences were slightly (1.3 times) more
susceptible to enzymatic cleavage than was 50-dAdTdCdA-
dA-30, none of the sequences was substantially more suscept-
ible (Figure 4B). On the other hand, for each set of sequences
with a given nucleotide (dD) ﬂanking the 50 end of the
50-dTdCdA-30 sequence, the 50-dDdTdCdAdG-30 sequence
was consistently less susceptible to cleavage than was
the 50-dDdTdCdAdA-30 or 50-dDdTdCdAdT-30 sequence.
These results indicate that, with the exception of the
50-dDdTdCdAdG-30 sequence, Endo IV tolerates a variety
of combinations of individual nucleotides ﬂanking the
50-dTdCdA-30 sequence and thus exhibits a broad preference
for the 50-dDdTdCdAdW-30 pentanucleotide sequence, where
dW represents dA or dT.
To analyze the effects of sequences ﬂanking the
monodeoxycytidine of the substrate on Endo IV activity in
more detail, we determined the kinetic parameters for the
hydrolysis of 50-(dA)7dAdAdCdAdA(dA)7-30,5 0-(dA)7-
dAdTdCdAdA(dA)7-30 or 50-(dA)8dGdTdCdAdG(dA)8-30
oligonucleotides, which were also used as substrates for the
experiments shown in Figure 4. We conﬁrmed that the 50
and 30 products of cleavage of these oligonucleotides, pre-
sumably at the 50 phosphodiester bond of the internal dC,
were acid-soluble under the assay conditions (Supplementary
Data). The kcat for the 50-dAdTdCdAdA-30 sequence was
increased 2.9-fold whereas the Km was largely unchanged
compared with the values for the 50-dAdAdCdAdA-30
sequence, resulting in a 3.7-fold increase in the kcat/Km
ratio (Table 3). Compared with the 50-dAdTdCdAdA-30
sequence, the 50-dGdTdCdAdG-30 sequence yielded a kcat
reduced by  50% but a similar Km. These results suggest
that the identity of the nucleotides in the 50-dDdDdCd-
DdD-30 sequence affects the rate of hydrolysis by Endo IV
without markedly affecting the afﬁnity for the substrate.
DISCUSSION
Substrate specificity of Endo IV
Previous biochemical analyses of Endo IV have been restric-
ted to partially puriﬁed preparations of the enzyme from
T4 phage-infected E.coli B cells (10,11,23,24). These previ-
ous studies revealed that the activity of the enzyme with
ssDNA was greater than that with dsDNA (11). The enzyme
did not cleave alkaline-denatured T4 genomic dsDNA con-
taining gluc-dHMC, but it did cleave phage fd ssDNA and
alkaline-denatured phage lambda dsDNA (10), both of
which contain dC. Cleavage of fd ssDNA by Endo IV yielded
oligonucleotides with 50-phosphate and 30-hydroxyl termini
and an average length of  50 bases (11), most of which
Figure 3. Cleavage of a phiX174-based oligonucleotide by Endo IV. A 45
base oligonucleotide based on the sequence of phiX174 ssDNA and labeled at
the 50 end with Cy5 was used as the substrate at a concentration of 10 mM for
assay of the activity of Endo IV (6.6, 3.3, 1.3, 0.66 or 0.33 mg/ml). The
reaction products were separated by electrophoresis on a 10% polyacrylamide
gel containing 7 M urea and visualized with an image analyzer. Lane (–)
represents a reaction mixture incubated in the absence of enzyme. Lane M
represents a mixture of oligonucleotides labeled at the 50 end with Cy5 and
with sequences identical to those of residues 1–18, 1–27, 1–32, 1–34, 1–38,
1–41 and 1–45 of the substrate. Cleavage sites of the substrate are indicated
by arrows with a size proportional to the relative extent of cleavage at the
corresponding position. Each dC in the substrate sequence is shown in
boldface.
4748 Nucleic Acids Research, 2006, Vol. 34, No. 17were not solubilized by trichloroacetic acid (10,11). The
cleavage of fd ssDNA into various discrete fragments was
also detected by PAGE analysis (23). The cleavage products
obtained with fd (10,11,24), M13 (24) or phiX174 (24)
ssDNA molecules exclusively contained dC at their 50
termini.
In the present study, we found that expression of Endo IV
in E.coli cells prevented cell growth and we therefore syn-
thesized the enzyme in vitro with the use of a wheat germ
cell-free protein synthesis system and puriﬁed it to homogen-
eity. Analysis of the activity of the puriﬁed enzyme demon-
strated that Endo IV catalyzes endonucleolytic cleavage of
ssDNA speciﬁcally at the 50 phosphodiester bond of dC, con-
sistent with the previous observations, and that the efﬁciency
of such cleavage is highly dependent on the identity of the
nucleotides surrounding the dC residue. The puriﬁed enzyme
did not cleave heat-denatured T4 genomic dsDNA containing
gluc-dHMC but did cleave heat-denatured dC-substituted T4
(T4dC) genomic dsDNA, showing that Endo IV alone is
capable of distinguishing between the absence or presence
of gluc-dHMC in ssDNA without a requirement for additional
factors.
We also observed that the digestion of phiX174 ssDNA,
heat-denatured T4dC genomic dsDNA and a phiX174-based
oligonucleotide by Endo IV was limited. Indeed, the cleavage
products of phiX174 ssDNA generated by Endo IV were
largely acid-insoluble under our assay conditions, whereas
subsequent treatment of these products with E.coli exonuc-
lease I rendered them acid-soluble (data not shown), as
demonstrated previously for Endo IV-mediated cleavage of
fd ssDNA (10,11). This latter observation also supports the
conclusion that Endo IV generates oligonucleotides contain-
ing 50-phosphate and 30-hydroxyl termini (10), given that
E.coli exonuclease I activity requires a 30-hydroxyl terminus
of ssDNA (30).
Sequence preference of Endo IV
A decrease in size of oligonucleotide substrates from 45 to
19 bases did not substantially affect the enzymatic activity
of Endo IV. However, the enzyme exhibited a marked prefer-
ence for the 50-dTdCdA-30 trinucleotide sequence, consistent
with previous analyses of the cleavage products of fd,
M13 and phiX174 ssDNA molecules (24). The 30 terminal
Table 3. Effects of dC-flanking sequences of the substrate on kinetic parameters of Endo IV
Oligonucleotide Km (mM) Relative Km kcat (min
 1) Relative kcat kcat/Km (mM
 1 min
 1) Relative kcat/Km
50-(dA)7dAdAdCdAdA(dA)7-30 23 1.0 0.34 1.0 0.015 1.0
50-(dA)7dAdTdCdAdA(dA)7-30 18 0.78 1.0 2.9 0.056 3.7
50-(dA)8dGdTdCdAdG(dA)8-30 17 0.74 0.52 1.5 0.031 2.1
TheactivityofEndoIVwasdeterminedbymeasurementoftheamountofacid-solublenucleotidesreleasedfromthesubstrate.Kineticparametersweredetermined
by a least-squares fit of the data in Lineweaver–Burk plots. The relative Km, relative kcat and relative kcat/Km were calculated by dividing the Km, kcat and kcat/Km
values for each substrate by those for 50-(dA)7dAdAdCdAdA(dA)7-30. Data are means from two independent experiments.
Figure 4. Sequence preference of Endo IV. The activity of Endo IV was determined by measurement of the amount of acid-soluble nucleotides released from the
substrate (10 mM). A series of 19 base 50-(dA)8dDdCdD(dA)8-30 oligonucleotides (A) and a series of 21 base 50-(dA)8dDdTdCdAdD(dA)8-30 oligonucleotides
(B) were used as substrates, where dD represents dA, dT or dG. The relative activity was calculated by dividing the enzymatic activity for each oligonucleotide
by that for 50-(dA)8dAdCdA(dA)8-30 or (dC)25 in (A) or by that for 50-(dA)8dAdTdCdAdA(dA)8-30 or (dC)25 in (B). Data are means from two independent
experiments.
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ducts thus consisted predominantly of dT and 50-dCdA-30,
respectively. In addition, the 50-dTdCdA-30 sequence appears
in fd ssDNA with an average frequency of 1 per 75 bases,
which may account for the previously identiﬁed average
length ( 50 bases) of the products generated by Endo IV
from fd ssDNA (11). The average frequencies of this trinuc-
leotide sequence in M13 (1 per 76 bases) and phiX174 (1 per
74 bases) ssDNA molecules are also similar to that for fd
ssDNA. We further demonstrated that Endo IV tolerated
various combinations of individual nucleotides ﬂanking the
50-dTdCdA-30 sequence, exhibiting a broad preference for
the 50-dDdTdCdAdW-30 sequences. These results suggest
that the enzyme preferentially recognizes short nucleotide
sequences that include 50-dTdCdA-30.
On the other hand, although Endo IV cleaved the phiX174
oligonucleotide substrate used in the present study at the three
sites, dG18–dC19, dG27–dC28 and dG32–dC33, within the
50-dGdCdA-30 or 50-dGdCdT-30 sequence, an efﬁcient cleav-
age at the dT41–dC42 site within the 50-dTdCdA-30 sequence
was not detected. This indicates that Endo IV prefers the
50-dGdCdA-30 or 50-dGdCdT-30 sequence to the 50-dTdCdA-
30 sequence in this substrate. However, in contrast to the
50-dGdCdA-30 or 50-dGdCdT-30 sequence located at the mid-
dle of this substrate, the 50-dTdCdA-30 sequence is quite
proximal to the 30 end of this substrate, suggesting that the
distance from a terminus to a cleavage site in oligo-
nucleotides may substantially affect cleavage efﬁciency at
the site.
Effect of a proximal dC on Endo IV-mediated cleavage
The dG32–dC33 site within the 50-dG31–dG32–dC33–dA34–
dC35-30 sequence of the phiX174 oligonucleotide substrate
used in the present study was more susceptible to cleavage
by Endo IV than was the 50-(dA)8dGdCdA(dA)8-30 substrate
by a factor of  6, even though both cleavage sites are
located within a 50-dGdCdA-30 sequence; this difference
was estimated by comparison of the amounts of enzyme
required for substrate cleavage (data not shown). In addition,
Endo IV cleaved the 50-dG31–dG32–dC33–dA34–dC35-30
sequence efﬁciently at dG32–dC33 but inefﬁciently at
dA34–dC35, suggesting that the presence of a dC residue
proximal to a cleavage site may enhance cleavage efﬁciency
at this site even when such a proximal dC is not cleaved
efﬁciently. The enzyme may thus preferentially cleave the
50-dTdCdA-30 sequence within dC-rich regions.
How might such a proximal dC contribute to cleavage
susceptibility? Kinetic analysis of Endo IV activity demon-
strated that an increase in hydrolysis rate, not an increase in
afﬁnity for the substrate, was responsible for the preference
of the enzyme for the 50-dDdTdCdAdW-30 sequence. We did
not identify any sequence that contributed to enzyme-
substrate afﬁnity. To avoid a multiplicity of cleavage sites,
we did not examine the cleavage of an oligonucleotide with
multiple dC residues as a substrate for kinetic analysis of
enzymatic activity. Determination of the kinetic parameters
of Endo IV for hydrolysis of oligonucleotides containing
the 50-dGdGdCdAdC-30 sequence of the phiX174 oligonuc-
leotide and with a single cleavage site may provide insight
into the effect of a proximal dC on cleavage efﬁciency.
Lack of stable T4dC DNA synthesis in the denA
 ,
gene 56
  background
A combination of detrimental mutations in denB and gene 56
allows synthesis of stable T4dC genomic DNA (6,16,17).
T4dC genomic DNA synthesized in such a denB
 , gene
56
  background is highly resistant to cleavage by Endo II
in vivo (6). Such a background reduces the incorporation of
gluc-dHMC into T4 genomic DNA by 91–97% as a result
of the deﬁciency in the gene 56 product (6). The presence
of such a small amount of gluc-dHMC in T4 genomic
DNA thus effectively inhibits Endo II activity, which was
thought to preferentially target long nucleotide sequences
consisting mostly of dC (6). The detection of only a few
cleavage sites in T4dC genomic DNA synthesized in a
denB
 , gene 42
 , gene 46
 , gene 56
  background (18)
also supported this latter notion, given that deﬁciencies in
both gene 42 and gene 56 result in a complete replacement
of gluc-dHMC with dC and that deﬁciencies in denB and
gene 46 prevent further degradation of cleavage products
generated by Endo II. Indeed, Endo II was subsequently
shown to prefer asymmetric dC-rich dsDNA sequences,
typically 15 bp sequences that conform to 50-dGdRdCdC-
dGdCdN/dTdTdGdGdCdNdGdC-30, where dR and dN
represent dA or dG and dA, dT, dG or dC, respectively,
and the slash indicates the position of the preferred
complementary-strand nick (21,22).
On the other hand, given that T4dC genomic DNA syn-
thesis is not observed in the denA
 , gene 56
  background
(6,16,17), it is likely that Endo IV effectively attacks T4dC
genomic DNA even in the presence of a small amount of
gluc-dHMC. Together, these observations suggest that Endo
IV recognizes dC-containing sequences that are shorter and
more frequent than are those targeted by Endo II. Indeed,
we have now shown that Endo IV preferentially recognizes
short nucleotide sequences that contain 50-dTdCdA-30.
Possible role of Endo IV in inhibition of replication of
dC-containing DNA
A deﬁciency in denB suppresses the lack or arrest of T4dC
genomic DNA synthesis in the gene 56
  (6,16,17) or gene
42
 , gene 46
 , gene 56
  (6) background, respectively. In
addition, T4dC phage mutants with a denB
+ background
cease synthesizing their genomic DNA within 30 min after
infection (6). Moreover, several point mutations in denB
that allow stable T4dC genomic DNA synthesis in the gene
56
  (4) or gene 42
 , gene 56
  (H. Ohshima et al., unpub-
lished data) background result in a complete loss of Endo
IV activity (conﬁrmed in vitro). Together, these various
observations suggest that a lack of Endo IV activity is
required for stable T4dC genomic DNA synthesis.
Although the denB product, Endo IV, is dispensable for
the normal shutoff of host genomic DNA synthesis after
infection with T4 phage (8), our present study has shown
that its expression in E.coli cells is lethal, indicating that
the enzyme alone is able effectively to inhibit host DNA syn-
thesis in the absence of other T4 phage-encoded proteins.
Given that the presence of Endo IV has little effect on the
degradation of T4dC (5) or host (3,7,8) genomic DNA, the
enzyme appears to specialize in inhibition of the replication
of dC-containing DNA.
4750 Nucleic Acids Research, 2006, Vol. 34, No. 17Replication forks contain regions of ssDNA, most promin-
ently in the lagging strand. Such ssDNA regions may become
potential substrates for Endo IV. Given that cleavage of the
lagging strand would result in a double-strand break, it is pos-
sible that the cleavage of several such adjacent ssDNA
regions at dC by Endo IV results in the accumulation of dam-
age to the replication fork and its eventual collapse. If so, the
existence of a small number of such ssDNA regions in vivo
will result in a limited number of sites cleaved by Endo IV
that yield dsDNA fragments, which may account for the pre-
vious observations that the enzyme has little effect on the
fragmentation (5) but effectively restricts the synthesis (6)
of T4dC genomic DNA. In vivo studies of the effects of
Endo IV on replication forks, such as by 2D gel analysis of
the structure of replication bubbles in E.coli cells, should
provide insight into the validity of this hypothesis.
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Supplementary Data are available at NAR Online.
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